Similar articles

• Somatostatin and the endocrine pancreas.

  Gerich JE. Gerich JE. Curr Top Mol Endocrinol. 1976;3:127-43. doi: 10.1007/978-1-4684-2598-7_9. Curr Top Mol Endocrinol. 1976. PMID: 211005 Review.
• Clinical implications of growth hormone release inhibiting hormone (GH-RIH).

  Besser GM. Besser GM. Curr Top Mol Endocrinol. 1976;3:115-25. doi: 10.1007/978-1-4684-2598-7_8. Curr Top Mol Endocrinol. 1976. PMID: 211004 Review. No abstract available.
• Somatostatin, basic and clinical studies. A review.

  Schally AV, Meyers CA. Schally AV, et al. Mater Med Pol. 1980 Jan-Jun;12(1-2):28-32. Mater Med Pol. 1980. PMID: 6120265 Review. No abstract available.
• Somatostatin.

  Efendić S, Hökfelt T, Luft R. Efendić S, et al. Adv Metab Disord. 1978;9:367-424. doi: 10.1016/b978-0-12-027309-6.50023-9. Adv Metab Disord. 1978. PMID: 347908 Review. No abstract available.
• [Somatostatin--hormone inhibitor (author's transl)].

  Sieradzki J. Sieradzki J. Przegl Lek. 1976;33(3):393-7. Przegl Lek. 1976. PMID: 1273332 Polish. No abstract available.